Clinical Research Collaborations: Practical Considerations for Israeli Life Sciences Companies

We are pleased to share our latest client update on clinical research collaborations and their strategic value for Israeli life sciences companies.

A recent JAMA Oncology study comparing federally and industry sponsored cancer clinical trials in the United States illustrates the distinct, yet complementary, roles that public and private research can play in the clinical research ecosystem.

The update considers key commercial and legal issues in collaborations with hospitals, investigators, technology transfer organizations, and public funding bodies, including data rights, intellectual property, publications, and future development opportunities.